Elevation Oncology, Inc. earnings per share and revenue

ELEV earnings per share for the last quarter are -0.22 USD whereas the estimation was -0.19 USD which accounts for -15.79% surprise. Company revenue for the same period amounts to 0.00 USD despite the estimated figure of 0.00 USD. Estimated earnings per share for the next quarter are -0.23 USD, and revenue is expected to reach 0.00 USD. Also watch annual changes over time to get a bigger picture of ELEV earnings per share and revenue dynamics.